Lee Jennifer Kayden — SEC Form 4 filings
SEC reporting owner CIK 1801372. 14 Form 4 filings on record with FilingPulse; latest filed 2026-08-14.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-02-05 to 2026-08-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 24 legs across 11 filings — 194,359 shares, $15,668,516 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 39.
- Largest priced transaction: sale of 75,834 shares @ $117.38 ($8,901,531) in RHYTHM PHARMACEUTICALS, INC., filed 2026-08-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | EVP, Head of North America | 14 | — | 24 legs · 194,359 sh · $15,668,516 | 39 |
Form 4 filings — Lee Jennifer Kayden
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-14 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 35,000 @ $24.29 · Option exercise (M): 21,601 @ $6.80 · Sale (S): 75,834 @ $117.38 · Option exercise (M): 35,000 (derivative) @ $0 · Option exercise (M): 21,601 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Grant/award (A): 21,650 (derivative) @ $0 · Grant/award (A): 32,500 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 22,612 · Tax withholding (F): 9,237 @ $108.99 · Option exercise (M): 3,437 (derivative) @ $0 · Option exercise (M): 4,512 (derivative) @ $0 · Option exercise (M): 5,500 (derivative) @ $0 · Option exercise (M): 9,163 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 5,500 · Sale (S): 2,035 @ $57.22 · Grant/award (A): 36,650 (derivative) @ $0 · Grant/award (A): 55,000 (derivative) @ $0 · Option exercise (M): 5,500 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Sale (S): 600 @ $56.39 · Sale (S): 10 @ $56.41 · Sale (S): 1,205 @ $56.39 · Sale (S): 1,205 @ $58 | EDGAR |
| 2025-02-11 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 3,437 · Option exercise (M): 4,189 @ $6.80 · Sale (S): 1,894 @ $58.39 · Sale (S): 2,295 @ $59.34 · Option exercise (M): 2,031 · Sale (S): 1,023 @ $57.51 · +4 more | EDGAR |
| 2025-02-07 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Sale (S): 1,733 @ $60.08 · Sale (S): 1,133 @ $61.01 · Sale (S): 200 @ $61.95 | EDGAR |
| 2025-02-04 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 4,513 · Sale (S): 1,447 @ $59.43 · Option exercise (M): 4,513 (derivative) @ $0 | EDGAR |
| 2024-11-13 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 20,622 @ $6.80 · Option exercise (M): 28,717 @ $24.29 · Option exercise (M): 11,642 @ $30.66 · Sale (S): 38,051 @ $65.68 · Sale (S): 17,540 @ $66.95 · Sale (S): 11,070 @ $67.56 · +4 more | EDGAR |
| 2024-03-22 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Sale (S): 9,169 @ $38.22 · Sale (S): 9,066 @ $39.33 | EDGAR |
| 2024-03-19 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Sale (S): 15,515 @ $39.22 | EDGAR |
| 2024-02-21 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Grant/award (A): 33,750 @ $0 · Grant/award (A): 22,000 (derivative) @ $0 · Grant/award (A): 67,000 (derivative) @ $0 | EDGAR |
| 2024-02-13 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 3,438 · Option exercise (M): 2,031 · Sale (S): 1,023 @ $51.38 · Sale (S): 615 @ $49.83 · Option exercise (M): 3,438 (derivative) @ $0 · Option exercise (M): 2,031 (derivative) @ $0 | EDGAR |
| 2024-02-05 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 4,513 · Sale (S): 1,492 @ $45.06 · Option exercise (M): 4,513 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1801372 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →